Drug
Signatera Ctdna Assay
Signatera Ctdna Assay: highest development phase Phase 2, developed by Natera. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Natera
Trials
| Drug | Phase | Indication |
|---|---|---|
| Signatera ctDNA assay NCT04786600 | Phase 2 | Metastatic Colorectal Cancer |
Latest
No recent events.
Follow Signatera Ctdna Assay on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.